Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to
Condition:   Prevention of Swine InfluenzaIntervention:   Biological: Swine InfluenzaSponsors:   Novartis Vaccines;   NovartisCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 16, 2013 Category: Research Source Type: clinical trials

Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to
Condition:   Prevention of Swine InfluenzaIntervention:   Biological: Swine InfluenzaSponsor:   Novartis VaccinesCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2013 Category: Research Source Type: clinical trials

Risk of Narcolepsy Associated With Administration of H1N1 Vaccine
Condition:   NarcolepsyIntervention:   Biological: A/H1N1 vaccineSponsors:   Hopital du Sacre-Coeur de Montreal;   GlaxoSmithKlineCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2011 Category: Research Source Type: clinical trials

Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
Condition:   Influenza Caused by the 2009 H1N1 Influenza VirusInterventions:   Other: Follow-up;   Other: Follow-upSponsor:   National Institute for Health and Welfare, FinlandCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 20, 2010 Category: Research Source Type: clinical trials

Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines
Condition:   Healthy VolunteersIntervention:   Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health Clinical Center (CC)Completed - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2010 Category: Research Source Type: clinical trials